Recall D-0853-2026

US Class II Ongoing · initiated 2026-09-04

Recalling firm

Pfizer, NY

Product

Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.

Reason for recall

Lack of Assurance of Sterility

← All recalls